ANUH PHARMA LTD.

Scale -

Revenue is 772 Rs Cr; Annual Growth is 17 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 12 %
Ebitda is 66.07 Rs Cr; in Top Quartile; Continuous Decline over 3 years
PBT is 16.93 Rs Cr; in Top Quartile
PAT is 41.05 Rs Cr; in Top Quartile; Continuous Decline over 3 years
Quarterly Revenue is 194 Rs Cr; in Top Quartile

Quarterly Profit is 11.42 Rs Cr; Continuous Decline over 3 Quarters

Profitability -

PBDIT Margin is 8.56 %; Annual Decline is -19 %; Continuous Decline over 3 years
PAT Margin is 5.31 %; Annual Decline is -26 %; Continuous Decline over 3 years

Return -

ROA is 7.36 %; in Top Quartile; Annual Decline is -21 %; Continuous Decline over 3 years
Asset Turnover is 145 %; in Top Quartile

ROCE is 15.43 %; Continuous Decline over 3 years
ROE is 11.65 %; Continuous Decline over 3 years

Efficiency -

Operating cash flow is -3.01 Rs Cr; Annual Decline is -108 %; in Bottom Quartile
Quick Ratio is 1.5; Continuous Decline over 3 years

Solvancy -

Debt/Equity is 0; Annual Decline is -100 %; in Bottom Quartile
Total Debt is 0 Rs Cr; Annual Decline is -100 %; in Bottom Quartile
Contingent Liabilities is 7.45 Rs Cr; Annual Decline is -71 %; 5 Year CAGR is -31 %; in Top Quartile

Quality -

Other Expenses/Total Expenses is 12 %; in Bottom Quartile

Operating cashflow/ebitda is -5 %; Annual Decline is -109 %; in Bottom Quartile
Operating cashflow/PAT is -7 %; Annual Decline is -109 %
Change in Inventories/Total Expenses is 1 %; Annual Growth is 446 %; Continuous Growth over 3 years; in Top Quartile
Current Tax/PAT is 37 %; Continuous Growth over 3 years
Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: